Ratings by BTIG (Timothy Chiang)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/12/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2019 | Flexion Therapeutics | FLXN | New Coverage | Buy (N/A) |
16.81 (25.09) |
49.26% | Details | |
| 8/12/2019 | Progenics Pharmaceuticals | PGNX | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2019 | Amneal Pharmaceuticals | AMRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2019 | Ironwood Pharmaceuticals | IRWD | Maintain | Buy (N/A) |
|
Details | ||
| 2/5/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/28/2018 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2018 | Solid Biosciences | SLDB | New Coverage | Neutral (N/A) |
28.68 (8.30) |
-71.06% | Details | |
| 11/7/2018 | Ironwood Pharmaceuticals | IRWD | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2018 | Synergy Pharmaceuticals | SGYP | Downgrade | Neutral (Buy) |
1.28 (0.03) |
-97.66% | Details | |
| 10/3/2018 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2018 | Teva Pharma | TEVA | Upgrade | Neutral (Sell) |
22.85 (32.20) |
40.92% | Details | |
| 9/13/2018 | Progenics Pharmaceuticals | PGNX | Maintain | Buy (N/A) |
|
Details |
